Induction of cyclin-dependent kinase 5 and its activator p35 through the extracellular-signal-regulated kinase and protein kinase a pathways during retinoic-acid mediated neuronal differentiation in human neuroblastoma SK-N-BE(2)C cells

Journal of Neurochemistry

Volumn 91, Issue 3, 2004, Pages 634-647

  Lee, Jong Hee ^a   Kim, Kyong Tai ^a  

^a Pohang University of Science and Technology (POSTECH)   (South Korea)

Author keywords

AP 1; Cyclin dependent kinase 5; Extracellular signal regulated kinase; Neuronal differentiation; p35; Retinoic acid

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLIN DEPENDENT KINASE 5; EARLY GROWTH RESPONSE FACTOR 1; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN C FOS; PROTEIN DERIVATIVE; PROTEIN P35; RETINOIC ACID; ROSCOVITINE; TRANSCRIPTION FACTOR AP 1;

ARTICLE; CONTROLLED STUDY; CYCLIC AMP RESPONSIVE ELEMENT; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MUTANT; NERVE CELL DIFFERENTIATION; NERVE FIBER GROWTH; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INDUCTION;

CELL DIFFERENTIATION; CELL LINE, TUMOR; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLIN-DEPENDENT KINASE 5; CYCLIN-DEPENDENT KINASES; DNA-BINDING PROTEINS; EARLY GROWTH RESPONSE PROTEIN 1; ENZYME INDUCTION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; IMMEDIATE-EARLY PROTEINS; NERVE TISSUE PROTEINS; NEURITES; NEUROBLASTOMA; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSFECTION; TRETINOIN;

EID: 7244260747     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2004.02770.x     Document Type: Article

References (51)

1. Agoston D. V., Palkovits C. G., Fizgerald S. F. and Brenneman D. E. (1995) Developmental changes in the inducibility of fos-like immunoreactivity in primary embryonic spinal cord cultures. Dev. Brain Res. 89, 173-186.
2. Cavanaugh J. E., Ham J., Hetman M., Poser S., Yan C. and Xia Z. (2001) Differential regulation of mitogen-activated protein kinases ERK1/2 and ERK5 by neurotrophins, neuronal activity, and cAMP in neurons. J. Neurosci. 21, 434-443.
3. Chen J., Zhang Y., Kelz M. B., Steffen C., Ang E. S., Zeng L. and Nestler E. J. (2000) Induction of cyclin-dependent kinase 5 in the hippocampus by chronic electroconvulsive seizures: role of ΔFosB. J. Neurosci. 20, 8965-8971.
4. Chen W., Yu Y. L., Lee S. F. et al. (2001) CREB is one component of the binding complex of the Ces-2/E2A-HLF binding element and is an integral part of the interleukin-3 survival signal. Mol. Cell. Biol. 21, 4636-4646.
5. Choi S. Y., Choi B. H., Suh B. C., Chae H. D., Kim J. S., Shin M. J., Kang S. S., Negishi M. and Kim K. T. (2001) Potentiation of PGE2-mediated cAMP production during neuronal differentiation of human neuroblastoma SK-N-BE (2) C cells. J. Neurochem. 79, 303-310.
6. Chung J., Uchida E., Grammer T. C. and Blenis J. (1997) STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation. Mol. Cell. Biol. 17, 6508-6516.
7. Connell-Crowley L., Le Gall M., Vo D. J. and Giniger E. (2000) The cyclin-dependent kinase Cdk5 controls multiple aspects of axon patterning in vivo. Curr. Biol. 10, 599-602.
8. Dhavan R. and Tsai L. H. (2001) A decade of Cdk5. Nat. Rev. Mol. Cell Biol. 2, 749-759.
9. Fu W. Y., Wang J. H. and Ip N. Y. (2002) Expression of Cdk5 and its activators in NT2 cells during neuronal differnetiation. J. Neurochem. 81, 646-654.
10. Ghigo D., Priotto C., Migliorino D., Geromin D., Franchino C., Todde R., Costamagna C., Gianpiero P. and Bosia A. (1998) Retinoic acid-induced differentiation in a human neuroblastoma cell line is associated with an increase in nitric oxide synthesis. J. Cell. Physiol. 174, 99-106.
11. Grant P., Sharma P. and Pant H. C. (2001) Cyclin-dependent protein kinase 5 (Cdk5) and the regulation of neurofilament metabolism Eur. J. Biochem. 268, 1534-1546.
12. Gruber J. R., Desai S., Blusztajn J. K. and Niles R. M. (1995) Retinoic acid specifically increases nuclear PKCα and stimulates AP-1 transcriptional activity in B16 mouse melanoma cells. Exp. Cell Res. 221, 377-384.
13. Harada T., Morooka T., Ogawa S. and Nishida E. (2001) ERK induces p35, a neuron-specific activator of Cdk5, through induction of Egrl. Nat. Cell Biol. 3, 453-459.
14. Hill C. S. and Treisman R. (1995a) Transcriptional regulation by extracellular signals: mechanisms and specificity. Cell 80, 199-211.
15. Hill C. S. and Treisman R. (1995b) Differential activation of c-fos promoter elements by serum, lysophosphatidic acid, G proteins and polypeptide growth factors. EMBO J. 14, 5037-5047.
16. Ishizuka T., Ino H., Sawa K., Suzuki N. and Tatibana M. (1995) Promoter region of the mouse cyclin-dependent kinase 5-encoding gene. Gene 166, 267-271.
17. Jenab S. and Inturrisi C. (2002) Retinoic acid regulation of mu opioid receptor and c-fos mRNAs and AP-1 DNA binding in SH-SY5Y neuroblastoma cells. Mol. Brain Res. 99, 34-39.
18. Kao S., Jaiswal R. K., Kolch W. and Landreth G. E. (2001) Identification of the mechanisms regulation the differential activation of the MAPK cascade by epidermal growth factor and nerve growth factor in PC 12 cells. J. Biol. Chem. 276, 18 169-18 177.
19. Karin M. (1995) The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270, 4730-4735.
20. -ΔΔCτ method. Methods 25, 402-408.
21. Kim S. N., Kim S. G., Park S. D., Cho-Chung Y. S. and Hong S. H. (2000) Participation of type II protein kinase A in the retinoic acid-induced growth inhibition of SH-SY5Y human neuroblastoma cells. J. Cell. Physiol. 182, 421-428.
22. Ko J., Humbert S., Bronson R. T., Takahashi S., Kulkarni A. B., Li E. and Tsai L. H. (2001) p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment. J. Neurosci. 21, 6758-6771.
23. Lonze B. E. and Ginty D. D. (2002) Function and regulation of CREB family transcription factors in the nervous system. Neuron 35, 605-623.
24. Maden M. (1999) Heads or tails? Retinoic acid will decide. Bioessays 21, 809-812.
25. Marshall C. J. (1995) Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 65, 663-675.
26. McCaffery P. and Dräger U. C. (2000) Regulation of retinoic acid signaling in the embryonic nervous system: a master differentiation factor. Cytokine Growth Factor Rev. 11, 233-249.
27. Miranda M. B., McGuire T. F. and Johnson D. E. (2002) Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines. Leukemia 16, 683-692.
28. Morooka T. and Nishida E. (1998) Requirement of p38 mitogen-activated protein kinase for neuronal differentiation in PC12 cells. J. Biol. Chem. 273, 24 285-24 288.
29. Muñoz J. P., Alejandra A. and Maccioni R. B. (2000) Increase in the expression of the neuronal cyclin-dependent protein kinase Cdk5 during differentiation of N2A neuroblastoma cells. Neuroreport 12, 2733-2738.
30. Nikolic M., Dudek H., Kwon Y. T., Ramos Y. F. and Tsai L. H. (1996) The Cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation. Genes Dev. 10, 816-825.
31. O'Donovan K. J., Tourtellotte W. G., Millbrandt J. and Baraban J. M. (1999) The EGR family of transcription-regulatory factors: progress at the interface of molecular and systems neuroscience. Trends Neurosci. 22, 167-173.
32. Ohshima T., Ward J. M., Huh C. G., Longenecker G., Veeranna L., Pant H. C., Brady R. O., Martin L. J. and Kulkarni A. B. (1996) Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proc. Natl Acad. Sci. USA 93, 11 173-11 178.
33. Ohshima T., Ogawa M., Veeranna, Hirasawa M., Longenecker G., Ishiguro K., Pant H. C., Brady R. O., Kulkarni A. B. and Mikoshiba K. (2001) Synergistic contributions of cyclin-dependant kinase5/p35 and Reelin/Dab1 to the positioning of cortical neurons in the developing mouse brain. Proc. Natl Acad. Sci. USA 98, 2764-2769.
34. Okamoto S., Krainc D., Sherman K. and Lipton S. A. (2000) Antiapoptotic role of the p38 mitogen-activated protein kinase-myocyte enhancer factor 2 transcription factor pathway during neuronal differentiation. Proc. Natl Acad. Sci. USA 97, 7561-7566.
35. Paglini G. and Cáceres A. (2001) The role of the Cdk5-p35 kinase in neuronal development. Eur. J. Biochem. 268, 1528-1533.
36. Paglini G., Pigino G., Kunda P., Morfini G., Maccioni R., Quiroga S., Ferreira A. and Cáceres A. (1998) Evidence for the participation of the neuron-specific Cdk5 activator p35 during laminin-enhanced axonal growth. J. Neurosci. 18, 9858-9869.
37. Reddy U. R., Basu A., Bannerman P., Ikegaki N., Reddy C. D. and Pleasure D. (1999) ZPK inhibits PKA induced transcriptional activation by CREB and blocks retinoic acid induced neuronal differentiation. Oncogene 18, 4474-4484.
38. Reffas S. and Schlegel W. (2000) Compartment-specific regulation of extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) mitogen-activated protein kinases (MAPKs) by ERK-dependent and non-ERK-dependent inductions of MAPK phosphatase (MKP)-3 and MKP-1 in differentiating P19 cells. Biochem. J. 352, 701-708.
39. Robinson M. J. and Cobb M. H. (1997) Mitogen-activated protein kinase pathways. Curr. Opin. Cell Biol. 9, 180-186.
40. Ross S. A., Mccaffery P. J., Drager U. C. and de Luca L. M. (2000) Retinoids in embryonal development. Physiol. Rev. 80, 1021-1054.
41. Ross S., Tienhaara A., Lee M. S., Tsai L. H. and Gill G. (2002) GC box-binding transcription factors control the neuronal specific transcription of the cyclin-dependent kinase 5 regulator p35. J. Biol. Chem. 277, 4455-4464.
42. Shaulian E. and Karin M. (2001) AP-1 in cell proliferation and survival. Oncogene 20, 2390-2400.
43. Silvagno F., Guarnieri V., Capizzi A. and Pescarmona G. P. (2002) Synergistic effect of retinoic acid and dehydroepiandrosterone on differentiation of human neuroblastoma cells. FEBS Lett. 532, 153-158.
44. Smith M. A., Parkinson D. R., Cheson B. D. and Friedman M. A. (1992) Retinoids in cancer therapy. J. Clin. Oncol. 10, 839-864.
45. Smith D. S., Greer P. L. and Tsai L. H. (2001) Cdk5 on the brain. Cell Growth Differ. 12, 277-283.
46. Stringer J. L., Belaguli N. S., Iyer D., Schwartz R. J. and Balasubramanyam A. (2002) Developmental expression of serum response factor in the rat central nervous system. Dev. Brain Res. 138, 81-86.
47. Thiels E., Knaterewicz B. I., Norman E. D., Trzaskos J. M. and Klann E. (2002) Long-term depression in the adult hippocampus in vivo involves activation of extracellular signal-regulated kinase and phosphorylation of Elk-1. J. Neurosci. 22, 2054-2062.
48. Traverse S., Gomez N., Paterson H., Marshall C. and Cohen P. (1992) Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor. Biochem. J. 288, 351-355.
49. Wang H., Ikeda S., Kanno S., Guang M., Ohnishi M., Sasaki M., Kobayashi T. and Tamura S. (2001) Activation of c-jun amino-terminal kinase is required for retinoic acid-induced neuronal differentiation of P19 embryonal carcinoma cells. FEBS Lett. 503, 91-96.
50. Zheng M., Leung C. L. and Liem R. K. (1998) Region-specific expression of cyclin-dependent kinase 5 (Cdk5) and its activators, p35 and p39, in the developing and adult rat central nervous system. J. Neurobiol. 35, 141-159.
51. Zukerberg L. R., Patrick G. N., Nikolic M., Humbert S., Wu C. L., Lanier L. M., Gertler F. B., Vidal M., Van Etten R. A. and Tsai L. H. (2000) Cables links Cdk5 and c-Ab1 and facilitates Cdk5 tyrosine phosphorylation, kinase upregulation, and neurite outgrowth. Neuron 26, 633-646.